Atlas Trials

Pharvaris Netherlands B.V.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pharvaris Netherlands B.V.

RecordFirmDate
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency (NCT07266805)Pharvaris Netherlands B.V.2025-10-16
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE (NCT06679881)Pharvaris Netherlands B.V.2025-02-01
Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE (NCT06669754)Pharvaris Netherlands B.V.2024-12-01
Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema (NCT06343779)Pharvaris Netherlands B.V.2024-02-26
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (NCT05396105)Pharvaris Netherlands B.V.2022-12-28
Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (NCT05047185)Pharvaris Netherlands B.V.2022-04-19
Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (NCT04618211)Pharvaris Netherlands B.V.2021-02-03

Track Pharvaris Netherlands B.V. automatically

Every clearance here is in the API, with alerts when new ones post.